DR info

臨床試験数 : 27 / 薬物数 : 30 - (DrugBank : 15) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 153

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

68Ga-NEB
   Peking Union Medical College Hospital
      2014   Phase 1   NCT02496013   China;
Bevacizumab
   University of California, San Francisco
      2016   Phase 1   NCT02314377   United States;
Bleomycin
   Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
      2016   -   ChiCTR-IOR-16008047   China;
      2014   -   ChiCTR-OOB-15007258   China;
Cobimetinib
   University of Arkansas
      2022   Phase 2   NCT05125471   -
Dexmedetomidine
   Nan Jiang
      2016   -   NCT03076099   China;
Dexmedetomidine 1
   First Affiliated Hospital, Sun Yat-Sen University
      2015   Phase 4   NCT02552459   China;
Dexmedetomidine 2
   First Affiliated Hospital, Sun Yat-Sen University
      2015   Phase 4   NCT02552459   China;
Dexmedetomidine 3
   First Affiliated Hospital, Sun Yat-Sen University
      2015   Phase 4   NCT02552459   China;
Doxycycline
   University of California, San Francisco
      2008   Phase 1   NCT00783523   United States;
      2004   Phase 1   NCT00243893   United States;
Ethanol
   Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
      2018   -   ChiCTR1800017616   China;
      2018   -   ChiCTR1800015220   China;
   Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong University
      2020   -   ChiCTR2000036597   China;
      2020   -   ChiCTR2000036576   China;
Haemoblock
   Center for Vascular Pathology, Moscow
      2020   Phase 4   NCT04999618   Russian Federation;
Heparin Sodium
   Beijing Tiantan Hospital
      2016   -   NCT03306836   China;
L04AA10
   CHRU TOURS
      2019   Phase 2   EUCTR2019-001530-33-FR   France;
Lipiodol® Ultra Fluid with surgical glues
   Guerbet
      2017   Phase 4   NCT02625389   India;
Lovastatin
   Beijing Tiantan Hospital
      2021   Phase 2   NCT04297033   China;
Mekinist
   Cliniques universitaires Saint-Luc
      -   Phase 2   EUCTR2019-003573-26-BE   Belgium;
Minocycline
   University of California, San Francisco
      2004   Phase 1   NCT00243893   United States;
Sirolimus
   Centre Hospitalier Universitaire, Amiens
      2014   Phase 2   NCT02042326   Belgium;France;
   Gifu University
      2017   -   JPRN-UMIN000030522   Japan;
Sirolimus 0, crème
   CHRU TOURS
      2019   Phase 2   EUCTR2018-001359-11-FR   France;
Sirolimus 1mg/mL
   CHRU TOURS
      2019   Phase 2   EUCTR2019-001530-33-FR   France;
Sufentanil
   First Affiliated Hospital, Sun Yat-Sen University
      2015   Phase 4   NCT02552459   China;
Thalidomide
   Northport Veterans Affairs Medical Center
      2006   Phase 2   NCT00389935   United States;
   Xuanwu Hospital, Capital Medical University
      2019   Phase 0   ChiCTR1900021901   China;
Uterine
   Henan Provincial People's Hospital
      2021   Phase 4   ChiCTR2100048193   China;